P2X4R and related signaling pathways were involved in EAAT3
regulation and trigeminal allodynia following repeated
dural stimulation. (a) WB for p-p38 expression in the TNC
(upper panel) revealed that p-p38 protein level was
increased in the IS group compared with the CON group.
TNP-ATP (30 nmol) treatment repressed its expression as
compared to the group of IS+PBS. Quantification (lower
panel) of WB experiments was normalized to actin control.
(b) WB for p38 expression in the TNC (upper panel)
revealed no evident difference among the four groups.
Quantification (lower panel) of WB experiments was
normalized to actin control. (c) to (f): WB for BDNF (c),
CGRP (d), c-Fos (e), EAAT3 (f) expression in the TNC
(upper panel) revealed that BDNF, CGRP, c-Fos, and EAAT3
were all upregulated following repeated dural stimulation
as compared to control. TNP-ATP (30 nmol) treatment
decreased their protein levels compared with the group of
IS+PBS. There were no obvious difference between the group
of IS and IS +PBS. Quantification (lower panel) of all WB
experiments was normalized to actin control. (g) TNP-ATP
treatment significantly increased the basal periorbital
pressure thresholds compared with IS+PBS group. The
IS+TNP-ATP (30 nmol) and IS+TNP-ATP (60 nmol) groups
showed no obvious difference in anti-nociceptive effect.
(h) and (i): WB for P2X4R (h), p-p38 (i) expression in the
TNC (upper panel) revealed that ANA-12 (100 nmol)
treatment did not reverse IS-induced P2X4R and p-p38
upregulation. Quantification (lower panel) of WB
experiments was normalized to actin control. Data
represent the mean ± SEM. Statistical
analyses were performed by one-way ANOVA, followed by a
Tukey test; *P < 0.05,
**P < 0.01,
***P < 0.001 vs. CON,
#P < 0.05,
##P < 0.01,
###P < 0.001 vs.
IS+PBS (n = 6 per group).
WB: western blot; IS: inflammatory soup; CON: control; PBS:
phosphate-buffered saline; BDNF: brain-derived
neurotrophic factor; CGRP: calcitonin gene-related
peptide; EAAT3: excitatory amino acid transporter 3.